European HealthTech Weekly: Sofinnova Closes €82M MedTech Fund, EU Launches AI Screening Hubs and Chip Initiative

Sofinnova Partners finalized an €82 million fund dedicated to launching and incubating up to eight early-stage medical device and hardware startups over the next five years.

The fund targets high-acuity interventional cardiology, robotics, and neuro-modulation sectors within the medical technology landscape.

The European Union opened an €80 million funding call via the Chips Joint Undertaking to integrate European-designed AI chips into public supercomputing facilities and health-data AI Factories.

This initiative aims to reduce long-term reliance on overseas compute clusters for training sovereign medical foundation models.

EU health officials are establishing AI-powered screening hubs across member states to improve early detection and intervention capabilities.

These screening hubs will leverage artificial intelligence to analyze medical data and identify health risks at earlier, more treatable stages.

The HealthTech sector also saw activity in venture financing, with companies like AnaCardio and Biolevate securing significant funding rounds.

Taken together, these developments represent significant advancement and investment in the European HealthTech ecosystem.

The initiatives demonstrate Europe's commitment to fostering innovation in medical technology and healthcare artificial intelligence.